Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

Open-Label Extension Study of PRX012 in Subjects with Alzheimer’s Disease Who Were Enrolled in Study PRX012-101 or PRX012-102 Ended

2023-503729-20-00 Alzheimer’s Disease 2024-03-27
Evaluation of the bioavailability of two products containing esomeprazole under fasting and fed conditions: Esomeprazole-Syrup 40 mg dose (T… Ended

2023-506701-18-00 No therapeutic indication in the current trial with hea 2024-03-27
Effect of Erythromycin on the absorption, metabolism and elimination of CHF6001 in healthy volunteers Ended

2023-507300-30-00 This study is a phase I trial to investigate the effec 2024-03-27
A trial to learn how much [11C]savolitinib enters the brains of healthy participants Ended

2023-508334-34-00 Healthy Volunteers 2024-03-27
A randomized, open-label, single dose, cross-over study to evaluate the drug-drug interaction between Proscar 5 mg, film-coated tablets and … Ended

2024-510774-24-00 healthy male subjects 2024-03-25
A Phase 1, open label, randomized, 2-sequence, 2-period, crossover, single center study to evaluate the pharmacokinetics of follitropin alfa… Ended

2023-507066-91-00 Infertility 2024-03-19
A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab via Subcutaneous Administration in Healthy Vol… Ended

2023-508041-40-00 healthy volunteers 2024-03-19
A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 are Tolerated and Act in the Body in Healthy Adults Ended

2023-509054-54-00 Heart failure 2024-03-19
Study in Participants With Normal Kidney Function and Reduced Kidney Function to Test How Kidney Function Can Change What Happens to Obeldes… Ended

2023-504780-17-00 Renal Impairment 2024-03-19
A PHASE 1, OPEN-LABEL, RANDOMIZED, THREE-PERIOD, THREE-TREATMENT, BALANCED, SIX-SEQUENCE CROSSOVER STUDY TO DETERMINE THE RELATIVE BIOAVAILA… Ended

2023-507661-26-00 Alzheimer’s Disease 2024-03-18
A study to assess the effect of single and repeated doses of JNJ-81241459 on a single dose of certain other drugs, when given together to he… Ended

2023-509030-19-00 Plaque Psoriasis 2024-03-18
A Phase 1b Study to Characterize the Safety and Tolerability of TEV-53408 in Adults with Celiac Disease Ended

2022-502817-27-00 Celiac disease 2024-03-15
A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors Ended

2023-504824-24-00 Arm A: Diagnosed with uterine serous carcinoma (USC) Ar 2024-03-15
A trial to learn how much budesonide, glycopyrronium, and formoterol fumarate (BGF) gets into and moves throughout the body when it is taken… Ended

2023-504089-43-00 Not applicable, healthy volunteers 2024-03-14
Study to Assess the Effect of Food on the Pharmacokinetics of CA-4948 in Healthy Male Subjects Ended

2023-509691-41-00 Hematologic malignancies 2024-03-14
A PHASE I, OPEN-LABEL, RANDOMIZED, ADAPTIVE, CROSS-OVER STUDY TO DETERMINE THE RELATIVE BIOAVAILABILITY OF NIZUBAGLUSTAT CAPSULES COMPARED T… Ended

2023-510058-17-00 Glycosphingolipid lysosomal storage disorders 2024-03-12
A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR) Ended

2023-507721-41-00 polymyalgia rheumatica 2024-03-11
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-1117570 in Healthy Adults Ended

2023-508814-40-00 Neurological and neuropsychiatric conditions 2024-03-11
A Phase 1b, Open-Label, Multiple Ascending Dose, Multicenter Study of VRG50635 in Participants With Sporadic and Familial Amyotrophic Latera… Ended

2023-506509-21-00 Amyotrophic Lateral Sclerosis 2024-03-08
A six-way relative bioavailability study comparing 10, 30, 40 and 50 mg leniolisib film coated tablets and 30 mg film coated granules with 7… Ended

2023-508880-61-00 Activated Phosphoinositide 3-Kinase Delta Syndrome 2024-03-06
Physiologically based pharmacokinetic modelling of intravenous and intranasal formulations of naloxone in healthy volunteers Ended

2023-506064-14-00 Healthy volunteers 2024-03-05
Double-Blind, Randomized, Placebo-Controlled, Phase 1b, Pharmacodynamic Trial of TEV-56192 Following a Single Intravenous Administration in … Ended

2023-507018-29-00 Pruritus 2024-03-05
A study to test whether multiple doses of BI 456906 have an effect on cardiac safety in people with overweight or obesity. Ended

2023-506375-10-00 Healthy volunteer trial 2024-03-04
A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Selnoflast in Participants with Moderate to Severe Asthma Ended

2023-504304-29-00 Moderate to Severe Asthma 2024-03-01